Revvity Inc. $RVTY Stake Lowered by Corient Private Wealth LP

Corient Private Wealth LP trimmed its stake in shares of Revvity Inc. (NYSE:RVTY) by 11.8% during the second quarter, Holdings Channel reports. The firm owned 160,410 shares of the company’s stock after selling 21,548 shares during the period. Corient Private Wealth LP’s holdings in Revvity were worth $17,847,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also made changes to their positions in RVTY. Public Employees Retirement System of Ohio acquired a new stake in Revvity in the second quarter worth $3,845,000. California State Teachers Retirement System lifted its stake in Revvity by 10,607.8% in the second quarter. California State Teachers Retirement System now owns 14,328,063 shares of the company’s stock valued at $1,594,140,000 after buying an additional 14,194,254 shares during the last quarter. Bank of New York Mellon Corp acquired a new position in shares of Revvity during the second quarter valued at $78,766,000. Tocqueville Asset Management L.P. bought a new position in shares of Revvity during the second quarter worth about $4,791,000. Finally, Corient Private Wealth LLC grew its position in shares of Revvity by 985.0% during the fourth quarter. Corient Private Wealth LLC now owns 126,568 shares of the company’s stock worth $12,245,000 after acquiring an additional 114,903 shares during the last quarter. Institutional investors own 86.65% of the company’s stock.

Analyst Ratings Changes

Several analysts recently weighed in on RVTY shares. Sanford C. Bernstein assumed coverage on shares of Revvity in a research report on Friday, June 26th. They issued a “market perform” rating and a $115.00 price objective on the stock. Zacks Research upgraded shares of Revvity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 4th. Wall Street Zen lowered shares of Revvity from a “buy” rating to a “hold” rating in a research note on Sunday, August 16th. Weiss Ratings raised Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 30th. Finally, TD Cowen reiterated a “buy” rating on shares of Revvity in a research report on Wednesday, July 15th. Four equities research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $116.57.

Revvity Stock Performance

Shares of RVTY opened at $128.57 on Tuesday. The firm has a 50-day moving average price of $118.03 and a 200 day moving average price of $103.47. The firm has a market capitalization of $14.35 billion, a PE ratio of 61.22, a P/E/G ratio of 2.26 and a beta of 1.09. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36. Revvity Inc. has a 52-week low of $81.22 and a 52-week high of $133.00.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.20. The company had revenue of $729.69 million for the quarter, compared to the consensus estimate of $702.96 million. Revvity had a net margin of 8.16% and a return on equity of 8.34%. Revvity’s revenue was down 1.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, sell-side analysts anticipate that Revvity Inc. will post 5.36 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be paid a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity’s dividend payout ratio (DPR) is currently 13.33%.

Revvity Profile

Revvity, Inc is a life sciences and diagnostics company that provides technologies, products and services used by researchers, healthcare professionals and laboratories. Its offerings support applications across genomics, proteomics, cellular analysis, drug discovery, disease research and laboratory testing.

The company develops and supplies scientific instruments, reagents, consumables, software and workflow solutions. Its portfolio includes platforms for genetic and molecular analysis, imaging, high-throughput screening, biomarker research and single-cell analysis, as well as laboratory solutions used in areas such as reproductive health and newborn screening.

Revvity was established in 2023 following the separation of PerkinElmer’s Applied, Food and Enterprise Services businesses from its Precision Diagnostics operations.